These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 13536246)
1. Relaxin: its effects in a case of acrosclerosis. ISMAY G Br J Dermatol; 1958 May; 70(5):171-5. PubMed ID: 13536246 [No Abstract] [Full Text] [Related]
2. Use of relaxin in the treatment of scleroderma. CASTEN GG; BOUCEK RJ J Am Med Assoc; 1958 Jan; 166(4):319-24. PubMed ID: 13491339 [No Abstract] [Full Text] [Related]
3. Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report. EVANS JA AMA Arch Derm; 1959 Feb; 79(2):150-8. PubMed ID: 13616712 [No Abstract] [Full Text] [Related]
4. Localized and systemic scleroderma. Hawk A; English JC Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134 [TBL] [Abstract][Full Text] [Related]
5. [Generalized scleroderma (acrosclerosis) treated with ACTH and cortisone; useful adjuvant role of methionine]. GOUGEROT H; AZERAD E; GRUPPER C Bull Soc Fr Dermatol Syphiligr; 1952; 59(2):126-9. PubMed ID: 12978808 [No Abstract] [Full Text] [Related]
6. RELAXIN IN THE TREATMENT OF LOCALISED SCLERODERMA. WELLS RS Trans St Johns Hosp Dermatol Soc; 1963; 49():149-51. PubMed ID: 14116132 [No Abstract] [Full Text] [Related]
7. Failure of relaxin inthe treatment of scleroderma. JEFFERIS JE; DIXON AS Ann Rheum Dis; 1962 Sep; 21(3):295-7. PubMed ID: 14028943 [No Abstract] [Full Text] [Related]
8. THE USE OF RELAXIN IN PROGRESSIVE SYSTEMIC SCLEROSIS AND OTHER CONNECTIVE TISSUE DISEASES. A CLINICAL STUDY. RIVELIS AL; TRAEGER C; ROGOFF B Arch Interam Rheumatol; 1965; 8():19-31. PubMed ID: 14316749 [No Abstract] [Full Text] [Related]
9. Esophageal lesions associated with acrosclerosis and scleroderma. OLSEN AM; O'LEARY PA; KIRKLIN BR Arch Intern Med (Chic); 1945 Oct; 76():189-200. PubMed ID: 21008494 [No Abstract] [Full Text] [Related]
10. SF-36 Scales in the Relaxin study. Khanna D; Park GS; Seibold J Rheumatology (Oxford); 2007 Apr; 46(4):724. PubMed ID: 17289790 [No Abstract] [Full Text] [Related]
11. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Rose RF; Turner D; Goodfield MJ; Goulden V Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995 [TBL] [Abstract][Full Text] [Related]
12. Diffuse systemic scleroderma. A comparison with acrosclerosis. TUFFANELLI DL; WINKELMANN RK Ann Intern Med; 1962 Aug; 57():198-203. PubMed ID: 13923026 [No Abstract] [Full Text] [Related]
13. [Favorable effects of prednisolone (deltacortril) in a case of progressive diffuse scleroderma]. WIEME RJ Belg Tijdschr Geneesk; 1956 May; 12(9):504-6. PubMed ID: 13328782 [No Abstract] [Full Text] [Related]
14. Management of scleroderma. Winkelmann RK; Kierland RR; Perry HD; Muller SA; Sams WM Mayo Clin Proc; 1971 Feb; 46(2):128-34. PubMed ID: 5546412 [No Abstract] [Full Text] [Related]
15. Generalized progressive scleroderma or acrosclerosis. CORNBLEET T; SCHORR H; KAGEN M Arch Derm Syphilol; 1948 Mar; 57(3 Pt. 2):446. PubMed ID: 18098650 [No Abstract] [Full Text] [Related]